Citi downgraded QuidelOrtho (QDEL) to Neutral from Buy with a price target of $33, down from $40. The firm cites a lack of upside to the company’s mid-single-digit growth outlook for the downgrade. Citi sees challenges with the LEX launch and higher interest expense pressuring QuidelOrtho’s fiscal 2025 earnings.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL: